Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut

[1]  M. Redinbo,et al.  A structural metagenomics pipeline for examining the gut microbiome. , 2022, Current opinion in structural biology.

[2]  J. Hasty,et al.  Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes , 2021, Cell.

[3]  Emily C. Gentry,et al.  High-confidence structural annotation of metabolites absent from spectral libraries , 2021, Nature Biotechnology.

[4]  B. Wallace,et al.  DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data , 2021, Protein science : a publication of the Protein Society.

[5]  C. Theriot,et al.  Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against Clostridioides difficile by Commensal Clostridium , 2021, Microorganisms.

[6]  R. Barrangou,et al.  Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization , 2021, Proceedings of the National Academy of Sciences.

[7]  J. Segre,et al.  Infection trains the host for microbiota-enhanced resistance to pathogens , 2021, Cell.

[8]  Mario L. Arrieta-Ortiz,et al.  In vivo commensal control of Clostridioides difficile virulence , 2020, bioRxiv.

[9]  J. Benes,et al.  Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection-an observational cohort study. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  D. A. Harris,et al.  Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects , 2020, Nature Chemical Biology.

[11]  John C. Macbeth,et al.  Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection , 2020, Cell.

[12]  Y. Hahn,et al.  Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health , 2020, Gut microbes.

[13]  Julie C. Lumeng,et al.  Global chemical effects of the microbiome include new bile-acid conjugations , 2020, Nature.

[14]  H. Sokol,et al.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[15]  Justin J. J. van der Hooft,et al.  Mass spectrometry searches using MASST , 2020, Nature Biotechnology.

[16]  Nils Oberg,et al.  The EFI Web Resource for Genomic Enzymology Web Tools: Leveraging Protein, Genome, and Metagenome Databases to Discover Novel Enzymes and Metabolic Pathways. , 2019, Biochemistry.

[17]  I. Tikhonova,et al.  The complex structure of bile salt hydrolase from Lactobacillus salivarius reveals the structural basis of substrate specificity , 2019, Scientific Reports.

[18]  Simon C. Potter,et al.  The EMBL-EBI search and sequence analysis tools APIs in 2019 , 2019, Nucleic Acids Res..

[19]  R. Barrangou,et al.  Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract , 2019, PLoS pathogens.

[20]  Thomas B. Clarke,et al.  Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection , 2019, Gut.

[21]  Xingzhen Lao,et al.  Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome , 2019, Microbiome.

[22]  T. Weir,et al.  The gut microbiota at the intersection of diet and human health , 2018, Science.

[23]  Casey M. Theriot,et al.  Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells , 2018, Science.

[24]  J. Walter,et al.  Lifestyles in transition: evolution and natural history of the genus Lactobacillus. , 2017, FEMS microbiology reviews.

[25]  M. Redinbo,et al.  An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. , 2017, Structure.

[26]  R. Thanissery,et al.  Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. , 2017, Anaerobe.

[27]  Tetsuya Ezawa,et al.  Ecological Base-Conditioned Preparation of Dipeptides Using Unprotected α-Amino Acids Containing Hydrophilic Side Chains , 2017 .

[28]  F. Shanahan,et al.  Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk , 2016, PloS one.

[29]  H. Gaskins,et al.  Taurocholic acid metabolism by gut microbes and colon cancer , 2016, Gut microbes.

[30]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[31]  Michael A. Fischbach,et al.  A biosynthetic pathway for a prominent class of microbiota-derived bile acids , 2015, Nature chemical biology.

[32]  D. Aronoff,et al.  Variation in germination of Clostridium difficile clinical isolates correlates to disease severity. , 2015, Anaerobe.

[33]  Philipp Stiefel,et al.  Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide , 2015, BMC Microbiology.

[34]  C. Hill,et al.  Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk , 2014, Gut microbes.

[35]  Jens Roat Kultima,et al.  An integrated catalog of reference genes in the human gut microbiome , 2014, Nature Biotechnology.

[36]  C. Hill,et al.  Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.

[37]  R. Britton,et al.  Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. , 2014, Gastroenterology.

[38]  T. Riley,et al.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.

[39]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[40]  James B. Mitchell,et al.  Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity , 2013, Nature Communications.

[41]  S. Prakash,et al.  Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications , 2013, Expert opinion on biological therapy.

[42]  Zhengwei Zhu,et al.  CD-HIT: accelerated for clustering the next-generation sequencing data , 2012, Bioinform..

[43]  Derrick W. Crook,et al.  Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  D. Aronoff,et al.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains , 2011, Gut microbes.

[45]  Tetsuya Hayashi,et al.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. , 2011, Gastroenterology.

[46]  Andrew J. Miles,et al.  A reference dataset for the analyses of membrane protein secondary structures and transmembrane residues using circular dichroism spectroscopy , 2011, Bioinform..

[47]  S. Sattar,et al.  Clospore: a liquid medium for producing high titers of semi-purified spores of Clostridium difficile. , 2011, Journal of AOAC International.

[48]  Anne M. Evans,et al.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.

[49]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[50]  D. Raftery,et al.  Bile Acids Conjugation in Human Bile Is Not Random: New Insights from 1H-NMR Spectroscopy at 800 MHz , 2009, Lipids.

[51]  Carlene A. Muto,et al.  Antimicrobial-associated risk factors for Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  Jun Ye,et al.  Crystal structure of the flavoprotein ArsH from Sinorhizobium meliloti , 2007, FEBS letters.

[53]  Adam Godzik,et al.  Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences , 2006, Bioinform..

[54]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[55]  R. Schultz-Heienbrok,et al.  Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product. , 2005, Biochemistry.

[56]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. , 2000, Analytical biochemistry.

[57]  N. Sreerama,et al.  Estimation of the number of α‐helical and β‐strand segments in proteins using circular dichroism spectroscopy , 2008, Protein science : a publication of the Protein Society.

[58]  Sean R. Eddy,et al.  Profile hidden Markov models , 1998, Bioinform..

[59]  K. Wilson.  Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination , 1983, Journal of clinical microbiology.

[60]  S. Provencher,et al.  Estimation of globular protein secondary structure from circular dichroism. , 1981, Biochemistry.